The National Service Framework for Older People
暂无分享,去创建一个
[1] Robert Baldwin. National Service Framework for Older People , 2003 .
[2] H. Kohli. Scottish Medicines Consortium. , 2005, The National medical journal of India.
[3] L. Friedhoff,et al. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial , 1996 .
[4] R. Kronmal,et al. Lessons from the Stroke Prevention in Atrial Fibrillation Trials , 2003, Annals of Internal Medicine.
[5] G. Ebers,et al. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.
[6] E. Krueger,et al. Subarachnoid Hemorrhage from an Aneurysm in a Patient with Thrombocytopenic Purpura , 1957, Neurology.
[7] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[8] Paul McCafferty,et al. Living independently: A study of the housing needs of elderly and disabled people , 1994 .
[9] A. Dart,et al. Age and the treatment gap in the use of statins , 2003, The Lancet.
[10] N. Dudley,et al. The influence of age on policies for admission and thrombolysis in coronary care units in the United Kingdom. , 1992, Age and ageing.
[11] J. Neilson. Assessment of fetal nuchal translucency test for Down's syndrome , 1997, The Lancet.
[12] K. Shulman,et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence , 2003, BMJ : British Medical Journal.
[13] N. Powe,et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. , 2000, Circulation.
[14] C. Warwick. The new NHS: modern dependable , 1998 .
[15] R. Tallis,et al. A new beginning for care for elderly people? , 2001, BMJ : British Medical Journal.
[16] C. Bulpitt,et al. The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848] , 2002, BMC health services research.
[17] Shaw Ab. Ensuring Equity and Quality of Care for Elderly People , 1995, Journal of the Royal College of Physicians of London.
[18] J A Paris,et al. Royal College of Physicians of London , 1848, Provincial medical & surgical journal.
[19] M. Mckee,et al. Rationing treatment on the NHS--still a political issue. , 2003, Journal of the Royal Society of Medicine.
[20] Thompson G. Robinson,et al. National Clinical Guidelines for Stroke. , 2001 .
[21] A. Bowling,et al. Age- and sex-related bias in the management of heart disease in a district general hospital. , 2002, Age and ageing.
[22] C. Bulpitt,et al. Hypertension in the Very Elderly Trial (HYVET) , 2001, Drugs & aging.
[23] J. Raftery,et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial , 2004, The Lancet.
[24] C. Bulpitt,et al. Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[25] Ludwig Kappos,et al. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis , 1998, The Lancet.
[26] Adelina Comas-Herrera,et al. Relying on informal care in the new century? Informal care for elderly people in England to 2031 , 2000, Ageing and Society.
[27] Bruno Vellas,et al. Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden , 2003, Journal of the American Geriatrics Society.
[28] B. O. Williams,et al. Clinical Trials in the Elderly , 1996 .
[29] P. Crome,et al. Appropriate prescribing in older people , 2002 .
[30] Alan Williams,et al. The rationing debate: Rationing health care by age: The case for , 1997 .
[31] Laing and Buisson,et al. Care of elderly people : market survey 2001 , 2001 .
[32] T. Strasser,et al. MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL , 1985, The Lancet.
[33] J. Rawles,et al. Women and myocardial infarction: agism rather than sexism? , 1995, British heart journal.
[34] D. Greenblatt,et al. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. 1978. , 1978, British journal of clinical pharmacology.
[35] Jingwu Z. Zhang,et al. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. , 2002, Clinical therapeutics.
[36] P. Crome. What's different about older people. , 2003, Toxicology.
[37] Mary T. Roth,et al. Secondary Prevention of Coronary Heart Disease in the Elderly , 2003, The Annals of pharmacotherapy.
[38] J. Castillo,et al. Public Perception of Stroke in Spain , 2003, Cerebrovascular Diseases.
[39] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[40] I. Starkey,et al. Elderly and younger patients selected to undergo coronary angiography. , 1991, BMJ.